| Vaccines Information Vaccine Development, Production Capacity, Global Distribution, Funding |
 |
|
February 24th, 2009, 09:25 AM
|
 |
Registered User
|
|
Join Date: Feb 2006
Location: germany
Posts: 8,620
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
hmm, same deletion as that what happened in human H1N1 1995 ?
kalign aligns it to the same positions
|
February 24th, 2009, 11:31 AM
|
|
Retired
|
|
Join Date: Feb 2006
Posts: 20,294
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
Quote:
Originally Posted by gsgs
hmm, same deletion as that what happened in human H1N1 1995 ?
kalign aligns it to the same positions
|
Aligning H1 with H5 can be tricky. Which H1 sequences have the deletion?
|
February 24th, 2009, 02:31 PM
|
|
Retired
|
|
Join Date: Feb 2006
Posts: 20,294
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
Quote:
Originally Posted by gsgs
hmm, same deletion as that what happened in human H1N1 1995 ?
kalign aligns it to the same positions
|
I looked harder at other serotypes and found two low path H5N2 sequences, but didn't see H1N1 from 1995. H2 is missing an amino acid in this area, but H2 doesn't have much homology with H5 in this region.
|
February 24th, 2009, 03:55 PM
|
|
Retired
|
|
Join Date: Feb 2006
Posts: 20,294
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
|
February 24th, 2009, 06:50 PM
|
|
Registered User
|
|
Join Date: Feb 2006
Location: germany
Posts: 8,620
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
see this paper about the K134 deletion in H1N1
http://vir.sgmjournals.org/cgi/content/full/88/12/3209
maybe the "same" position as far as one can compare H5 and H1
> reinsertion of K134 revealed the requirement of a compatible neuraminidase
also N1
these deletions are rare
the common ancestor of H5 and H1 is presumably more than ~400 years ago
|
February 24th, 2009, 08:25 PM
|
 |
Editor, Senior Moderator
|
|
Join Date: Mar 2006
Posts: 8,703
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
Quote:
Originally Posted by niman
|
Commentary
Shanxi H5N1 Clade 7 Changes Raise Pandemic Concerns
Recombinomics Commentary 20:31
February 24, 2009
China's National Avian Infleunza Reference Laboratory at Harbin have deposited two new gene sequences (HA and NS) for the clade 7 isolate, A/chicken/Shanxi/2/2006, from the 2006 outbreak in Shanxi. In addition to changes in several single nucleotide polymorphisms, the new HA sequence has the 3 BP deletion that is in two other clade 7 sequences from Hunan, A/chicken/Hunan/2246/2006 and A/chicken/Hunan/2292/2006. This deletion is also in 12 clade 2.2 sequences from Egypt, including human isolates from the 2006/2007 season as well as the 2007/2008. The sharing of the identical 3 BP deletion by isolates from two distinct H5N1 clades provides compelling evidence for acquisition via homologous recombination. Moreover, sequences with the 3 BP deletion, as well as other sequences from Egypt, including sequences from vaccine resistant isolates share additional polymorphisms with the Shanxi sequence.
The new interest in the Shanxi sequence by the National Labs at Harbin adds to the circumstantial evidence that most or all of the six confirmed cases not discussed in the recent WHO report on H5N1 vaccine targets are clade 7, which was also reported for the Jiangsu poultry outbreak in China at the end of the year.
Although the WHO report did not discuss clade 7 in China, the variation in clade 7 in Vietnam was discussed because of the low cross reactivity between 2008 clade 7 isolates. The reduced cross reactivity between clade 7 isolates from the same country and year signals rapid evolution of clade 7, and the limited cross reactivity with antisera directed against clade 1 or clade 2 increases concerns.
The concerns regarding the rapid evolution of clade 7 in Vietnam are increased by the failure of WHO to discuss the six confirmed cases in China, including the Beijing isolate. A/Beijing/1/2009, which was from a fatal infection that began just after the clade 7 outbreak in Jiangsu.
Moreover, the sharing of polymorphisms between vaccine resistant clade 7 in China, and vaccine resistant clade 2.2 in Egypt raises concerns that these polymorphisms are being exported from China via migratory birds, contributing to worldwide vaccine failure.
Release of the 2009 human H5N1 sequences in China, Vietnam, and Egypt would be useful.
.
__________________
"The next major advancement in the health of American people will be determined by what the individual is willing to do for himself"-- John Knowles, Former President of the Rockefeller Foundation
|
February 24th, 2009, 08:29 PM
|
|
Editor, Senior Moderator
|
|
Join Date: Mar 2006
Posts: 8,703
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
Quote:
|
rapid evolution of clade 7
|
Why would this clade evolve more rapidly than others? If it's evolutionary fitness, what are the specifics?
.
__________________
"The next major advancement in the health of American people will be determined by what the individual is willing to do for himself"-- John Knowles, Former President of the Rockefeller Foundation
|
February 24th, 2009, 09:17 PM
|
|
Retired
|
|
Join Date: Feb 2006
Posts: 20,294
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
Quote:
Originally Posted by AlaskaDenise
Why would this clade evolve more rapidly than others? If it's evolutionary fitness, what are the specifics?
.
|
Vietnam has clade 1, clade 2.3.4, clade 2.3.2, and clade 7 co-circulating through poultry, which produces a lot of recombination and rapid evolution.
|
February 24th, 2009, 09:33 PM
|
|
Retired
|
|
Join Date: Feb 2006
Posts: 20,294
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
Quote:
Originally Posted by gsgs
these deletions are rare
the common ancestor of H5 and H1 is presumably more than ~400 years ago
|
Can you cite a single H5 earlier than 1959?
|
February 24th, 2009, 09:41 PM
|
|
Retired
|
|
Join Date: Feb 2006
Posts: 20,294
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
Quote:
Originally Posted by gsgs
|
The above paper describes a deletion that led to current H1N1's. These current H1's match H5's in the region where the 3 BP deletion leads to an additional loss in H5. The deleted H5 is deleted relative to H5 or H1 (it actually matches H2, but H2 has little homology in the region where the H5 aa is deleted.
|
February 25th, 2009, 09:46 AM
|
|
Retired
|
|
Join Date: Feb 2006
Posts: 20,294
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
|
February 25th, 2009, 03:16 PM
|
|
Editor, Senior Moderator
|
|
Join Date: Mar 2006
Posts: 8,703
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
Quote:
Originally Posted by niman
|
Commentary
Rapid H5N1 Clade 7 Evolution in Vietnam Raises Concerns
Recombinomics Commentary 14:31
February 25, 2009
Antigenic diversity is also present within clade 7 and viruses such as A/chicken/Vietnam/NCDV-03/2008 show reduced reactivity with antisera to clade 7 reference strain A/chicken/Vietnam/NCDV-016/2008.
The above comments are from the latest WHO update on H5N1 vaccine targets and represents concerns of a rapidly evolving clade 7 in Vietnam. The basis for the concern can be seen in the antisera table, where the vaccine against 016 has a titer of 320, which drops to 40 for 03. This drop is also suggested in the phylogenetic tree at the end of the report because of the length of each clade 7 node. Thus, even though both 016 and 03 are on the same branch, the length of each branch is relatively long, representing multiple changes.
Moreover, there are even more difference between the clade 7 in Vietnam and the clade 7 in China, represented by Shanxi/2. However, Shanxi/2 was from 2006 and China has already reported a clade 7 outbreak at the end of 2008, which likely has additional changes. Moreover, the clade 7 outbreak in poultry was followed by a spike in human cases, including A/Beijing/1/2009, which was almost certainly due to clade 7. The last human case in Beijing was in 2003 and was also clade 7, and clade 7 is common in poultry in areas surrounding Beijing.
The WHO report is glaringly silent on clade 7 in China. The Jiangsu outbreak was in December and sequences were generated last year because the OIE report noted the similarity with Shanxi/2. However, the Jiangsu poultry sequences are not on the tree and the only two human sequences from China in 2009 were from an infection with clade 2.3.4 or clade 2.3.2. There is not representation or comment on the other six confirmed cases, five of which were prior to the clade 2.3.2 infection. Moreover, the Beijing case began in 2008 and the sequences were described in general terms in media reports in early 2009.
The lack of any recent clade 7 sequences from China is cause for concern, as is the rapid evolution of clade 7 in Vietnam. In Vietnam, clade 7, clade 2.3.4, and clade 1 are co-circulating, providing opportunities for co-infections which lead to reassortant and recombination. Similarly, in China clade 7, clade 2.3.4 and clade 2.3.2 are co-circulating, offer similar opportunities. In fact the clade 2.3.2 from wild birds in Hong Kong, as well as the outbreaks South Korea, Japan, and Russia is a reassortant with a clade 2.3.2 HA and clade 2.3.4 in the other seven gene segments. Recombination between the clades and sub-clades leads to rapid evolution and vaccine resistance.
Thus, in addition to limited or no cross reactivity between clade 1 or 2 with clade 7, the published data supports rapid clade 7 involvement within clade 7. Thus, the vaccine against a 2008 clade 7 isolates from Vietnam has poor cross reactivity with another 2008 clade 7 isolate from Vietnam.
This rapid evolution of clade 7 in Vietnam, coupled with the absence of data on the current clade 7 circulating in China increase pandemic concerns.
.
__________________
"The next major advancement in the health of American people will be determined by what the individual is willing to do for himself"-- John Knowles, Former President of the Rockefeller Foundation
|
February 25th, 2009, 03:29 PM
|
|
Editor, Senior Moderator
|
|
Join Date: Mar 2006
Posts: 8,703
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
Why would some areas, like China and Vietnam, have multiple circulating clades, while other areas have fewer or even only one circulating clade?
Is there any comparison to the human influenza norm, ie., one strain, with the cause of exceptions (like the current 2 As) being significant prior recent immunity (to H1N1) when a new strain (H3N2) attempts dominance?
.
__________________
"The next major advancement in the health of American people will be determined by what the individual is willing to do for himself"-- John Knowles, Former President of the Rockefeller Foundation
|
February 26th, 2009, 01:36 AM
|
|
Registered User
|
|
Join Date: Feb 2006
Location: germany
Posts: 8,620
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
why are there more species of birds,beetles,... in some areas ?
All sorts of reasons. Airtravel is one of them. Weather,habitats,
Also several strains within H1N1,H3N3, 5-10 per season in USA
so 5-10 independent introductions.
Rarely both H1 and H3 cause widespread infections, usually
there are "H1-seasons" and "H3-seasons". Last season was an exception,
2006/7 also. So presumably they infer some protection/immunity
to each other during the same season
Last edited by gsgs; February 26th, 2009 at 06:18 AM.
Reason: typo
|
February 26th, 2009, 05:39 AM
|
|
Retired
|
|
Join Date: Feb 2006
Posts: 20,294
|
|
Re: WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines (Feb. 2009)
Quote:
Originally Posted by AlaskaDenise
Why would some areas, like China and Vietnam, have multiple circulating clades, while other areas have fewer or even only one circulating clade?
Is there any comparison to the human influenza norm, ie., one strain, with the cause of exceptions (like the current 2 As) being significant prior recent immunity (to H1N1) when a new strain (H3N2) attempts dominance?
.
|
The seasonal flu examples are of two different serotypes, while all of the sub-clades and clades mentioned for Vietnam are of the same serotype (H5). Genetic exchanges between members of the same serotype are much more common, which is why most of the examples of recombination look like SNPs.
|
|
|
|
Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
|
|
|
| Thread Tools |
Search this Thread |
|
|
|
| Display Modes |
 Linear Mode
|
Posting Rules
|
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
HTML code is On
|
|
|
Disclaimer:
The reader is responsible for discerning the validity, factuality or implications of information posted here, be it fictional or based on real events. Moderators on this forum make every effort to review the material posted on this site however, it is not realistically possible for our staff to manually review each post.
The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original authors or posters and are not endorsed by, or representative of the opinions of, the owners or administration of this website. The posts on this website are the opinion of the specific author or poster and should not be construed as statements of advice or factual information.
Not all posts on this website are intended as truthful or factual assertion by their authors. NO posts on this website should be considered factual information on face value alone. Users are encouraged to USE DISCERNMENT and do their own follow up research while reading and posting on this website. FluTrackers.com Inc. reserves the right to make changes to, corrections and/or remove entirely at any time posts made on this website without notice. In addition, FluTrackers.com Inc. disclaims any and all liability for damages incurred directly or indirectly as a result of a post on this website.
This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall FluTrackers.com Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site.
Finally, FluTrackers.com Inc. reserves the right to delete, correct, or make changes to any post on this website without notice at any time for any reason.
Fair Use Notice:
This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to public health, civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes.
In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember you are responsible for what you post on the internet and you could be sued by the original copyright holder if you do not honor these rules.
If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright
we may be contacted concerning copyright matters at:
FluTrackers.com Inc.
c/o Sharon Sanders
1676 Hibiscus Avenue
Winter Park, Florida 32789
Phone: 407-406-3037
E-Mail: flutrackers@earthlink.net
In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein.
If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.
All 3rd party material posted on this website is the copyright of the respective owners / authors. FluTrackers.com Inc. makes no claim of copyright on such material.
For more information please visit:
http://www.law.cornell.edu/uscode/17/107.shtml
Please be aware any communications sent complaining about a post on this website may be posted publicly at the discretion of the administration.
FluTrackers Does Not Provide Any Medical Advice:
FluTrackers, Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
By using and/or accessing this site, either passively or actively, you are agreeing to all of the above conditions. Also, by using and/or accessing this site, either passively or actively, you agree to conduct all business and legal affairs related to this website in the jurisdiction of Flutrackers.com Inc. which is registered in Central Florida, USA.
These Disclaimers are subject to change at anytime.
Email the Webmaster with questions or comments about this site at flutrackers@earthlink.net
All times are GMT -4. The time now is 05:14 PM.
|
